Artificial Intelligence in Cancer Diagnostics Market Size - Share Outlook, Growth Analysis Report and Forecast Trends (2026-2035)

Artificial Intelligence in Cancer Diagnostics Market Overview

Artificial intelligence in cancer diagnostics refers to the application of advanced algorithms to improve cancer detection AI, leveraging imaging biomarkers, histopathology AI, and early detection algorithms for accurate diagnosis. The market is growing due to the increasing adoption of liquid biopsy AI and data-driven tools. The market reached a value of approximately USD 1.74 Billion in 2025, supported by advancements in clinical decision support and diagnostic efficiency. These technologies enhance diagnostic efficiency, enable better patient stratification, and support informed treatment planning, positioning AI as a critical component in improving global cancer care outcomes.

Artificial Intelligence in Cancer Diagnostics Market Growth Drivers

Rising Prevalence of Cancer to Fuel the AI Adoption in the Market

The growing number of people living with cancer is a key factor driving the growth in the market. According to the American Association for Cancer Research (AACR), nearly 20 million people were new cancer cases occurred, while more than 10.3 million people died due to cancer. Increasing cancer prevalence, coupled with the need for early detection, accurate staging, and personalized treatment, is encouraging healthcare providers to deploy AI-powered imaging, predictive analytics, and clinical decision support tools, as well as screening automation, mammography AI, colonoscopy AI, and ctDNA analysis, accelerating market growth and improving diagnostic efficiency during the forecast period.

Artificial Intelligence in Cancer Diagnostics Market Trends

Key trends shaping the market include integration of artificial intelligence in early lung cancer.

Growing Integration of AI in Early Lung Cancer Detection to Enhance the Market Landscape

The market is witnessing a rising demand for early cancer diagnosis and growing adoption of AI-driven radiology tools, which are driving innovation in cancer care. For instance, in January 2026, Bristol Myers Squibb partnered with Microsoft to deploy AI-enabled radiology tools for early lung cancer detection, integrating FDA-cleared algorithms into clinical workflows. This initiative is expected to improve diagnostic accuracy, accelerate treatment initiation, and expand adoption of AI in cancer diagnostics throughout the forecast period.

Artificial Intelligence in Cancer Diagnostics Market Segmentation

Artificial Intelligence in Cancer Diagnostics Market Share

Breast Cancer to Dominate the Market Segment by Cancer Type

The market, based on the cancer type, includes breast cancer, lung cancer, brain cancer, colorectal cancer, prostate cancer, and others. Among these, breast cancer recorded a significant revenue share of more than 19% in the historical period. According to SEER cancer incidence, globally, about 316,950 new female breast cancer cases were estimated in 2025, underscoring the widespread disease burden and diagnostic demand. This large patient population is driving the adoption of AI diagnostics and clinical decision support tools to improve early detection accuracy and personalized care.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Global Artificial Intelligence in Cancer Diagnostics Market Analysis by Region

The regions included in the market are North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Among these, North America dominated the market in the historical period, accounting for the largest revenue share of over 54%. The region’s leadership is driven by advanced healthcare infrastructure, high adoption of AI diagnostics, and strong presence of major technology and healthcare companies. Integration of clinical decision support, radiology AI, predictive analytics, and multi-omics integration further strengthens market growth and accelerates precision oncology adoption.

Leading Players in Artificial Intelligence (AI) in Cancer Diagnostics Market

Other key players in the market are Mursla Bio, SkinVision, Kheiron Medical Technologies Limited, Tempus AI, Inc., Paige AI Inc., and Therapixel.

Key Questions Answered in the Artificial Intelligence in Cancer Diagnostics Market

• What was the artificial intelligence in cancer diagnostics market value in 2025?
• What is the artificial intelligence in cancer diagnostics market forecast outlook for 2026-2035?
• What major factors aid the demand for artificial intelligence in cancer diagnostics market?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market’s major drivers, opportunities, and restraints?
• What are the major artificial intelligence in cancer diagnostics market trends?
• Which offering is expected to dominate the market segment?
• Which cancer type is projected to lead the market segment?
• Which end user is projected to lead the market segment?
• Who are the key players in the artificial intelligence in cancer diagnostics market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?